Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema

Autoři	VALERIEVA Anna STAEVSKA Maria JESENAK Milos HRUBISKOVA Katarina SOBOTKOVA Marta ZACHOVA Radana HAKL Roman ANDREJEVIC Sladjana SUITER Tobias GRIVCHEVA-PANOVSKA Vesna KARADZA-LAPIC Ljerka SOTERES Daniel SHAPIRO Ralph RUMBYRT Jeffrey TACHDJIAN Raffi MEHTA Vinay HSU F. Ida ZANICHELLI Andrea
Rok publikování	2020
Druh	Článek v odborném periodiku
Časopis / Zdroj	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
Fakulta / Pracoviště MU	Lékařská fakulta
Citace
www	http://dx.doi.org/10.1016/j.jaip.2019.08.011
Doi	https://doi.org/10.1016/j.jaip.2019.08.011
Klíčová slova	C1-INHIBITOR; ATTACKS; DEFICIENCY; EFFICACY
Popis	Hereditary angioedema (HAE), an inherited deficiency offunctional C1 esterase inhibitor (C1-INH), is characterized byrecurrent episodes of disabling and often painful swelling insubcutaneous and/or submucosal tissues.1HAE attacks aregenerally unpredictable, but triggers for an attack can includehaving a dental or medical procedure (eg, surgery), other trauma,or stress. A preemptive management plan for patients under-going these types of situations may reduce the risk of HAE at-tacks. Recommendations include administration of short-termprophylaxis in patients with HAE before invasive medical pro-cedures, especially those involving the upper airways or digestivetract, with C1-INH concentrate typically the medication ofchoice.